Best Practices in the Treatment and Management of Melanoma: Expert Strategies on Evolving Combinations for Optimized Patient Outcomes

Hussein A. Tawbi

Best Practices in the Treatment and Management of Melanoma: Expert Strategies on Evolving Combinations for Optimized Patient Outcomes

Melanoma Medical Oncology

Research output: Contribution to journal › Article › peer-review

Abstract

Prior to 2011 there were no therapeutic options that significantly improved survival with advanced melanoma. There are now 13 targeted and immunotherapy options. The numerous treatment options have led to tremendous improvement in overall survival (OS).

Original language	English (US)
Pages (from-to)	41-44
Number of pages	4
Journal	Journal of Managed Care Medicine
Volume	26
Issue number	3
State	Published - 2023

ASJC Scopus subject areas

Health Policy

Cite this

@article{a488050fade5481c9dd4ad541ee5f18c,

title = "Best Practices in the Treatment and Management of Melanoma: Expert Strategies on Evolving Combinations for Optimized Patient Outcomes",

abstract = "Prior to 2011 there were no therapeutic options that significantly improved survival with advanced melanoma. There are now 13 targeted and immunotherapy options. The numerous treatment options have led to tremendous improvement in overall survival (OS).",

author = "Tawbi, {Hussein A.}",

year = "2023",

language = "English (US)",

volume = "26",

pages = "41--44",

journal = "Journal of Managed Care Medicine",

issn = "1094-1525",

publisher = "National Association of Managed Care Physicians",

number = "3",

}

TY - JOUR

T1 - Best Practices in the Treatment and Management of Melanoma

T2 - Expert Strategies on Evolving Combinations for Optimized Patient Outcomes

AU - Tawbi, Hussein A.

PY - 2023

Y1 - 2023

N2 - Prior to 2011 there were no therapeutic options that significantly improved survival with advanced melanoma. There are now 13 targeted and immunotherapy options. The numerous treatment options have led to tremendous improvement in overall survival (OS).

AB - Prior to 2011 there were no therapeutic options that significantly improved survival with advanced melanoma. There are now 13 targeted and immunotherapy options. The numerous treatment options have led to tremendous improvement in overall survival (OS).

UR - http://www.scopus.com/inward/record.url?scp=85188957707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85188957707&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85188957707

SN - 1094-1525

VL - 26

SP - 41

EP - 44

JO - Journal of Managed Care Medicine

JF - Journal of Managed Care Medicine

IS - 3

ER -

Best Practices in the Treatment and Management of Melanoma: Expert Strategies on Evolving Combinations for Optimized Patient Outcomes

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this